Traditional Chinese medicine causing hepatotoxicity in patients with chronic hepatitis B infection: A 1-year prospective study

Alimentary Pharmacology and Therapeutics

Volumn 24, Issue 8, 2006, Pages 1179-1186

  Yuen, M F ^a   Tam, S ^a   Fung, J ^a   Wong, D K H ^a   Wong, B C Y ^a   Lai, C L ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ABRIC ACID; ABRIN; AGKISTRODON ACUTUS EXTRACT; ALISMA ORIENTALE EXTRACT; ANTHRAQUINONE; CASSIA OBTUSIFOLIA EXTRACT; FENFLURAMINE; GLYCOSIDE; GLYCYRRHIZA URALENSIS EXTRACT; GLYCYRRHIZIC ACID; HERBACEOUS AGENT; MELIA TOOSENDAN EXTRACT; MENTHA HAPLOCALYX EXTRACT; N NITROSOFENFLURAMINE; NATURAL PRODUCT; PENNYROYAL OIL; POLYGONUM MULTIFORUM EXTRACT; PULEGONE; RHEUM PALMATUM EXTRACT; SCOLOPENDRA SUBSPINIPES MUTILANS EXTRACT; TOOSENDANIN; UNCLASSIFIED DRUG; ZAOCYS DHUMNADES EXTRACT;

ADULT; AGKISTRODON ACUTUS; ALISMA ORIENTALE; ARTICLE; BLOOD TOXICITY; CASSIA OBTUSIFOLIA; CHINESE MEDICINE; CLINICAL ARTICLE; DEATH; DISEASE EXACERBATION; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG CONTAMINATION; DRUG EFFICACY; DRUG FATALITY; DRUG FORMULATION; DRUG SAFETY; FEMALE; GLYCYRRHIZA URALENSIS; HEMOLYTIC ANEMIA; HEPATITIS; HEPATITIS B; HOSPITALIZATION; HUMAN; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LIVER TOXICITY; LIVER TRANSPLANTATION; MALE; MELIA TOOSENDAN; MENTHA HAPLOCALYX; MORTALITY; MULTIPLE ORGAN FAILURE; NEPHROTOXICITY; NONHUMAN; POLYGONUM MULTIFORUM; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHUBARB; SCOLOPENDRA SUBSPINIPES MUTILANS; TREATMENT OUTCOME; ZAOCYS DHUMNADES;

ADULT; DRUGS, CHINESE HERBAL; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33748899824     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.03111.x     Document Type: Article

References (33)

1. Schiano TD. Hepatotoxicity and complementary and alternative medicines. Clin Liver Dis 2003; 7: 453-73.
2. Stedman C. Herbal hepatotoxicity. Semin Liver Dis 2002; 22: 195-206.
3. Kessler RC, Davis RB, Foster DF, et al. Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med 2001; 135: 262-9.
4. Borum ML. Fulminant exacerbation of autoimmune hepatitis after the use of Ma huang. Am J Gastroenterol 2001; 96: 1654-5.
5. Kamiyama T, Nouchi T, Kojima S, et al. Autoimmune hepatitis triggered by administration of an herbal medicine. Am J Gastroenterol 1997; 92: 703-4.
6. Strader DB, Bacon BR, Lindsay KL, et al. Use of complementary and alternative medicine in patients with liver disease. Am J Gastroenterol 2002; 97: 2391-7.
7. Stickel F, Patsenker E, Schuppan D. Herbal hepatotoxicity. J Hepatol 2005; 43: 901-10.
8. Wong VW, Law MY, Hui AY, et al. A hospital clinic-based survey on traditional Chinese medicine usage among chronic hepatitis B patients. Complement Ther Med 2005; 13: 175-82.
9. Shaw D, Leon C, Kolev S, Murray V. Traditional remedies and food supplements. A 5-year toxicological study (1991-1995). Drug Saf 1997; 17: 342-56.
10. Wong WM, Wu PC, Yuen MF, et al. Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection. Hepatology 2000; 31: 201-6.
11. Danan G, Benichou C. Causality assessment of adverse reactions to drugs: I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993; 46: 1323-30.
12. Martindale: The extra pharmacopoeia. Martindale W, Reynolds JEF, eds. London: Royal Pharmaceutical Society, 1993.
13. Pharmacology and applications of Chinese Materia Medica. Chang HM, Butt PPH, eds. New Jersey: World Scientific Publishing, 2001.
14. Panis B, Wong DR, Hooymans PM, et al. Recurrent toxic hepatitis in a Caucasian girl related to the use of Shou-Wu-Pian, a Chinese herbal preparation. J Pediatr Gastroenterol Nutr 2005; 41: 256-8.
15. Li FK, Lai CK, Poon WT, et al. Aggravation of non-steroidal anti-inflammatory drug-induced hepatitis and acute renal failure by slimming drug containing anthraquinones. Nephrol Dial Transplant 2004; 19: 1916-7.
16. Park GJ, Mann SP, Ngu MC. Acute hepatitis induced by Shou-wu-pian, a herbal product derived from Polygonum multiflorum. J Gastroenterol Hepatol 2001; 16: 115-7.
17. But PPH. Hepatitis related to the Chinese medicine Shou-wu-pian manufactured from Polygonum multiforum. Vet Human Toxicol 1996; 38: 280-2.
18. Lau G, Lo D, Yao YJ, et al. A fatal case of hepatic failure possibly induced by N-nitrosofenfluramine. Med Sci Law 2004; 44: 252-63.
19. Kanda T, Yokosuka O, Tada M, et al. Nnitrosofenfluramine hepatotoxicity resembling chronic hepatitis. J Gastroenterol Hepatol 2003; 18: 999-1000.
20. Critchley LA, Chen DQ, Chu TT, et al. Pre-operative hepatitis in a woman treated with Chinese medicines. Anaesthesia 2003; 58: 1096-100.
21. Vanderperren B. Acute liver failure with renal impairment related to the abuse of senna anthraquinone glycosides. Ann Pharmacother 2005; 39: 1353-7.
22. Bakerink JA, Gospe SM, Dimand RJ, et al. Multiple organ failure after ingestion of pennyroyal oil from herbal tea in two infants. Pediatrics 1996; 98: 944-7.
23. Vallence WB. Pennyroyal poisoning: a fatal case. Lancet 1955; 269: 850-1.
24. Sullivan JB, Rumack BH, Thomas H Jr, et al. Pennyroyal oil poisoning and hepatotoxicity. JAMA 1979; 242: 2873-4.
25. Anderson IB, Mullen WH, Meeker JE. Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature. Ann Intern Med 1996; 124: 726-34.
26. Liu J, Lin H, McIntoch H. Genus Phyllanthus for chronic hepatitis B virus infection: a systemic review. J Viral Hepat 2001; 8: 358-66.
27. Chan HL, Sung JJ, Fong WF, et al. Double-blinded placebo-controlled study of Phyllanthus urinaris for the treatment of chronic hepatitis B. Aliment Pharmacol Ther 2003; 18: 339-45.
28. Thyagarajan SP, Subramanian S, Thirunalasundari T, et al. Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus. Lancet 1988; 2: 764-6.
29. Leelarasamee A, Trakulsomboon S, Maunwongyathi P, et al. Failure of Phyllanthus amarus to eradicate hepatitis B surface antigen from symptomless carriers. Lancet 1990; 30: 1600-1.
30. Blumberg BS, Millman I, Venkateswaran PS, et al. Hepatitis B virus and primary hepatocellular carcinoma: treatment of HBV carriers with Phyllanthus amarus. Vaccine 1990; 8 (Suppl.): S86-92.
31. Berk L, de Man RA, Schalm SW, et al. Beneficial effects of Phyllanthus amarus for chronic hepatitis B, not confirmed. J Hepatol 1991; 12: 405-6.
32. Milne A, Hopkirk N, Lucas CR, et al. Failure of New Zealand hepatitis B carriers to respond to Phyllanthus amarus. N Z Med J 1994; 107: 243.
33. Dourakis SP, Papanikolaou IS, Tzemanakis EN, et al. Acute hepatitis associated with herb ( Teucrium capitatum L.) administration. Eur J Gastroenterol Hepatol 2002; 14: 693-5.